Ignite Creation Date:
2025-12-24 @ 4:09 PM
Ignite Modification Date:
2025-12-27 @ 6:20 PM
Study NCT ID:
NCT01154166
Status:
COMPLETED
Last Update Posted:
2018-08-06
First Post:
2010-06-29
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Phase III, Randomised, Double-blind, Placebo-controlled, Parallel Group Study of Six Months Treatment With Ropinirole PR as Adjunctive Therapy in Patients With Parkinson's Disease Who Are Not Optimally Controlled on L-Dopa
Sponsor:
GlaxoSmithKline
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2010-02-15
Start Date Type:
None
Primary Completion Date:
2011-09-01
Primary Completion Date Type:
ACTUAL
Completion Date:
2011-09-29
Completion Date Type:
ACTUAL
First Submit Date:
2010-06-29
First Submit QC Date:
None
Study First Post Date:
2010-06-30
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2012-05-10
Results First Submit QC Date:
None
Results First Post Date:
2012-08-07
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2018-06-18
Last Update Post Date:
2018-08-06
Last Update Post Date Type:
ACTUAL